To further characterize the role of the Y5R in promoting low BMI-induced neuronal NPY-mediated tumor growth, we utilized CRISPR/Cas9 technology to knockout Y5r in a murine CMT167 lung cancer model. Here, NPY is linked to lung carcinoma.